Callum Hicks, Ph.D.

2016- Center for Substance Abuse Research Temple University, Philadelphia, PA, United States 
Neuroscience, Neuropharmacology, Addiction
"Callum Hicks"
Mean distance: 17.72 (cluster 19)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hicks C, Sabino V, Cottone P. (2020) The Alpha-1 Adrenergic Receptor Antagonist Prazosin Reduces Binge-Like Eating in Rats. Nutrients. 12
Simmons SJ, Leyrer-Jackson JM, Oliver CF, et al. (2018) Dark Classics in Chemical Neuroscience: "Cathinone-derived Psychostimulants". Acs Chemical Neuroscience
Hicks C, Huang P, Ramos L, et al. (2018) Dopamine D1-like receptor agonist and D2-like receptor antagonist (-)-Stepholidine reduces reinstatement of drug-seeking behavior for 3,4-methylenedioxypyrovalerone (MDPV) in rats. Acs Chemical Neuroscience
Philogene-Khalid HL, Hicks C, Reitz AB, et al. (2017) Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats. Drug and Alcohol Dependence. 178: 119-125
Sabino V, Hicks C, Cottone P. (2017) Sigma Receptors and Substance Use Disorders. Advances in Experimental Medicine and Biology. 964: 177-199
Hicks C, Gregg RA, Nayak SU, et al. (2017) Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG). Psychopharmacology
Ramos L, Hicks C, Caminer A, et al. (2016) MDMA ('Ecstasy'), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors. Pharmacology, Biochemistry, and Behavior
Hicks C, Ramos L, Dampney B, et al. (2016) Regional c-Fos expression induced by peripheral oxytocin administration is prevented by the vasopressin 1A receptor antagonist SR49059. Brain Research Bulletin
Gregg RA, Hicks C, Nayak SU, et al. (2016) Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator. Neuropharmacology
Ramos L, Hicks C, Caminer A, et al. (2015) Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. Psychopharmacology. 232: 2631-41
See more...